pyrimethamine has been researched along with Schistosomiasis mansoni in 6 studies
Maloprim: contains above 2 cpds
Schistosomiasis mansoni: Schistosomiasis caused by Schistosoma mansoni. It is endemic in Africa, the Middle East, South America, and the Caribbean and affects mainly the bowel, spleen, and liver.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In a small study in eastern Sudan, the effects of the treatment of uncomplicated, Plasmodium falciparum malaria with artesunate-sulfamethoxypyrazine-pyrimethamine (AS-SMP) and artemether-lumefantrine (AT-LU) on co-infections with Schistosoma mansoni were therefore investigated." | 9.13 | The antischistosomal efficacies of artesunate-sulfamethoxypyrazine-pyrimethamine and artemether-lumefantrine administered as treatment for uncomplicated, Plasmodium falciparum malaria. ( Abdalla, E; Adam, I; Elhadi, MO; Elhardello, OA; Elmardi, KA; Jansen, FH, 2008) |
| "The efficacy and safety of oral artesunate+sulfadoxine/pyrimethamine (AS+SP) (4 mg/kg AS for 3 consecutive days+25 mg sulfadoxine on Day 0) in the treatment of Schistosoma mansoni infections were compared with those of praziquantel (PZQ) (40 mg/kg) among infected schoolchildren (46 in each study arm) in eastern Sudan." | 5.14 | Artesunate plus sulfadoxine/pyrimethamine versus praziquantel in the treatment of Schistosoma mansoni in eastern Sudan. ( Adam, I; Ahmed, Ael A; Eldein, WN; Gasim, GI; Magzoub, M; Mahgoub, HM; Mohamed, AA, 2009) |
| " In a small study in eastern Sudan, the effects of the treatment of uncomplicated, Plasmodium falciparum malaria with artesunate-sulfamethoxypyrazine-pyrimethamine (AS-SMP) and artemether-lumefantrine (AT-LU) on co-infections with Schistosoma mansoni were therefore investigated." | 5.13 | The antischistosomal efficacies of artesunate-sulfamethoxypyrazine-pyrimethamine and artemether-lumefantrine administered as treatment for uncomplicated, Plasmodium falciparum malaria. ( Abdalla, E; Adam, I; Elhadi, MO; Elhardello, OA; Elmardi, KA; Jansen, FH, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mohamed, AA | 1 |
| Mahgoub, HM | 1 |
| Magzoub, M | 1 |
| Gasim, GI | 1 |
| Eldein, WN | 1 |
| Ahmed, Ael A | 1 |
| Adam, I | 2 |
| Utzinger, J | 1 |
| Tanner, M | 1 |
| Keiser, J | 1 |
| Obonyo, CO | 1 |
| Muok, EM | 1 |
| Mwinzi, PN | 1 |
| Fortin, A | 1 |
| Jansen, FH | 2 |
| Elhardello, OA | 1 |
| Elhadi, MO | 1 |
| Abdalla, E | 1 |
| Elmardi, KA | 1 |
| Miller, JM | 1 |
| Boyd, HA | 1 |
| Ostrowski, SR | 1 |
| Cookson, ST | 1 |
| Parise, ME | 1 |
| Gonzaga, PS | 1 |
| Addiss, DG | 1 |
| Wilson, M | 1 |
| Nguyen-Dinh, P | 1 |
| Wahlquist, SP | 1 |
| Weld, LH | 1 |
| Wainwright, RB | 1 |
| Gushulak, BD | 1 |
| Cetron, MS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Open-label, Randomized Clinical Trial in Kenya to Determine the Effectiveness of Artesunate + Sulfamethoxypyrazine/Pyrimethamine Vs. Praziquantel in the Treatment of S. Mansoni in Children[NCT01054651] | Phase 3 | 212 participants (Actual) | Interventional | 2009-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for pyrimethamine and Schistosomiasis mansoni
| Article | Year |
|---|---|
Artesunate plus sulfadoxine/pyrimethamine versus praziquantel in the treatment of Schistosoma mansoni in eastern Sudan.
Topics: Adolescent; Animals; Anthelmintics; Antimalarials; Artemisinins; Artesunate; Child; Drug Combination | 2009 |
Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomised controlled trial.
Topics: Adolescent; Amebicides; Animals; Antiprotozoal Agents; Artemisinins; Artesunate; Child; Child, Presc | 2010 |
The antischistosomal efficacies of artesunate-sulfamethoxypyrazine-pyrimethamine and artemether-lumefantrine administered as treatment for uncomplicated, Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; | 2008 |
3 other studies available for pyrimethamine and Schistosomiasis mansoni
| Article | Year |
|---|---|
ACTs for schistosomiasis: do they act?
Topics: Adolescent; Adult; Animals; Anthelmintics; Child; Child, Preschool; Herbal Medicine; Humans; Infant; | 2010 |
ACTs for the treatment of schistosomiasis.
Topics: Animals; Anthelmintics; Artemisinins; Artesunate; Humans; Pyrimethamine; Schistosoma mansoni; Schist | 2011 |
Malaria, intestinal parasites, and schistosomiasis among Barawan Somali refugees resettling to the United States: a strategy to reduce morbidity and decrease the risk of imported infections.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Child; Child, Preschool; Coccidiosis; Cryptosporidi | 2000 |